Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.7K
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

1
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
1

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Resistance to novel β-lactam/β-lactamase inhibitors among carbapenem-resistant <i>Pseudomonas aeruginosa</i> and clinical implications in the prospective observational <i>Pseudomonas</i> study.

Antimicrobial agents and chemotherapy·2026
Same author

Test Performance and Clinical Utility of the Cobas Eplex Blood Culture Identification Fungal Pathogen Panel.

Open forum infectious diseases·2026
Same author

Epidemiology and Clinical Features of Cryptococcosis Among Individuals Without HIV Infection: An Observational International Multicenter Study (MSG-11).

Open forum infectious diseases·2026
Same author

Development Framework of Desirability of Outcome Ranking Endpoints for Use in Clinical Trials of Invasive Fungal Diseases.

Open forum infectious diseases·2026
Same author

Histopathologic Insights Into Curvularia-Induced Chronic Granulomatous Fungal Sinusitis: A Guide for Surgical Pathologists.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2025
Same author

Dalbavancin for Treatment of Staphylococcus aureus Bacteremia: The DOTS Randomized Clinical Trial.

JAMA·2025

Related Experiment Video

Updated: Jun 5, 2025

Author Spotlight: Exploring Cytoskeletal Dynamics to Unveil Novel Antibiotics Through Innovative Cell-Based Assays
05:57

Author Spotlight: Exploring Cytoskeletal Dynamics to Unveil Novel Antibiotics Through Innovative Cell-Based Assays

Published on: April 26, 2024

775

New Perspectives on Antimicrobial Agents: Rezafungin.

Nicholas M Forrister1, Todd P McCarty1,2, Peter G Pappas1

  • 1Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.

Antimicrobial Agents and Chemotherapy
|December 12, 2024
PubMed
Summary
This summary is machine-generated.

Rezafungin offers a new treatment option for invasive candidiasis, reducing hospital stays. Its long half-life allows for weekly dosing, potentially aiding prophylaxis in high-risk patients.

Keywords:
anti-fungal agentscandidemiaechinocandininvasive candidiasis

More Related Videos

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.7K
Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
08:45

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance

Published on: December 28, 2017

13.7K

Related Experiment Videos

Last Updated: Jun 5, 2025

Author Spotlight: Exploring Cytoskeletal Dynamics to Unveil Novel Antibiotics Through Innovative Cell-Based Assays
05:57

Author Spotlight: Exploring Cytoskeletal Dynamics to Unveil Novel Antibiotics Through Innovative Cell-Based Assays

Published on: April 26, 2024

775
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.7K
Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
08:45

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance

Published on: December 28, 2017

13.7K

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Pharmacology

Background:

  • Candidemia and invasive candidiasis are major causes of illness and death.
  • Rising fluconazole resistance necessitates alternative antifungal treatments.
  • Current alternatives like extended echinocandin therapy or triazoles have drawbacks.

Purpose of the Study:

  • To review recent data on rezafungin for invasive candidiasis.
  • To evaluate rezafungin's antifungal activity, pharmacokinetics, and clinical efficacy.
  • To explore rezafungin's potential for outpatient management and prophylaxis.

Main Methods:

  • Review of recent published literature on rezafungin.
  • Analysis of antifungal activity and pharmacokinetic data.
  • Examination of clinical trial results for invasive candidiasis treatment.

Main Results:

  • Rezafungin demonstrates antifungal activity against Candida species.
  • Its pharmacokinetic profile supports once-weekly dosing due to a prolonged half-life.
  • Clinical data suggests efficacy in treating invasive candidiasis with potential for shorter hospital stays.

Conclusions:

  • Rezafungin presents a promising alternative for invasive candidiasis treatment.
  • Its dosing regimen may reduce healthcare burden and improve patient management.
  • Further studies are investigating rezafungin's role in antifungal prophylaxis for at-risk populations.